The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Polymorphic Forms Of Rad1901-2Hcl - EP3565542

The patent EP3565542 was granted to Radius Pharmaceuticals on Apr 10, 2024. The application was originally filed on Jan 5, 2018 under application number EP18736577A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3565542

RADIUS PHARMACEUTICALS
Application Number
EP18736577A
Filing Date
Jan 5, 2018
Status
Granted And Under Opposition
Mar 8, 2024
Publication Date
Apr 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSJan 10, 2025VON KAUFFMANNADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2011124617
INTERNATIONAL-SEARCH-REPORTUS2013116232
INTERNATIONAL-SEARCH-REPORTWO2014203129
INTERNATIONAL-SEARCH-REPORTWO2016176665
OPPOSITIONEP1797038
OPPOSITIONUS7612114
OPPOSITIONWO2011143469
OTHERUS7612114
OTHERUS8399520
OTHERUS8933130
OTHERWO2016176665
SEARCHWO2016176665

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents